Wantai SARS-CoV-2 total antibody rapid test is intended for screening of patients suspected for infection with the SARS-CoV-2 virus, an aid in the diagnosis of the COVID-19 disease.
- Fast: clear answer within only 15 minutes
- Easy-to-use: no special equipment. Works with whole blood, serum or plasma samples
- Performance: sensitivity of 94.70% (125/132) and specificity of 98.89% (268/271). The test has been clinically validated during the 2020 COVID-19 outbreak in China.
- Lateral Flow Test: suitable for rapid, on-site testing
The Wantai SARS-CoV-2 total antibody rapid test is manufactured and approved for use by the Therapeutic Goods Administration (TGA) .
Buy Wantai SARS-CoV-2 total antibody rapid test for Your WorkPlace
If your company or organisation is interested in rapid testing solutions, contact us today for help procuring the Wantai SARS-CoV-2 total antibody rapid test or other rapid tests authorised by the Therapeutic Goods Administration (TGA) .
If you’re interested in rapid testing solutions, contact us today for a quote. You can also place an order for the Wantai SARS-CoV-2 total antibody rapid test or other rapid tests approved by the TGA.
Our team at Rapid Tests Australia can also assist with implementing a rapid testing program to protect your workplace from the risks of COVID-19.